reports
MEDICREA Reports Third Quarter 2020 Sales
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the third quarter of 2020. (€ millions) YTD September 2019 YTD September 2020 Variation USA Rest of the world Total Sales Including Q3 13.7 10.6 24.3 8.2 12.6 8.7 21....
MEDICREA Reports First Half 2020 Results
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the first half of 2020, as approved by the Board of Directors on August 28, 2020. €’million Q1 2020 Q2 2020 H1 2020 H1 2019 Sales Gross margin in % of sales EBITDA (1...
MEDICREA Announces the Appointment of an Independent Expert
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announces the appointment of an independent expert. Following the announcement of the voluntary and friendly cash tender offer for the shares of Medicrea International (Euronext Growth Paris: FR0004178572 - ALMED, PEA-PME e...
Medtronic to Acquire Medicrea
DUBLIN & LYON, France--(BUSINESS WIRE)-- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants, today announced that they have entered into a tender offer agreement for the acquisition of all outstanding shares of Medicrea. The friendly voluntary all-cash tender offer will be at a price of €7.00 per Medicrea share (the “Tender Offer”). The Boards of Director...
MEDICREA Reports First Half 2020 Sales
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the first half of 2020. (€ millions) H1 2019 H1 2020 Variation Variation at Constant Exchange Rate USA Rest of the world Total Sales 8.7 7.4 16.1 7.6 5.6 13.2 -13%...
- Jehanne Leroy
Médicréa International - Assemblée Générale des actionnaires du 2...
La société propose de renouveler le mandat de 6 administrateurs dans les résolutions 6 à 11. La société n'a adhéré à aucun code de gouvernement d'entreprise ce qui se ressent au niveau d'un manque d'indépendance du conseil d'administration. Le conseil doit s'ouvrir à plus de diversité : accueillir une première femme et remplacer les administrateurs présents depuis l'introduction en bourse alors même que l'action cote toujours en dessous de son prix d'introduction. Au regard du manque d'indépenda...
- Jehanne Leroy
Médicréa International - Assemblée Générale 25 juin 2020
La société propose de renouveler le mandat de 6 administrateurs dans les résolutions 6 à 11. La société n'a adhéré à aucun code de gouvernement d'entreprise ce qui se ressent au niveau d'un manque d'indépendance du conseil d'administration. Le conseil doit s'ouvrir à plus de diversité : accueillir une première femme et remplacer les administrateurs présents depuis l'introduction en bourse alors même que l'action cote toujours en dessous de son prix d'introduction. Au regard du manque d'indépenda...
MEDICREA Reports 2020 First Quarter Results
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the first quarter of 2020. €’million Q1 2019 Q1 2020 Sales Gross margin in % of sales EBITDA (1) In % of sales Operating income Other operating income and expense ...
MEDICREA Reports 2019 Annual Results and 2020 First Quarter Sales
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes its 2019 IFRS annual results, as audited and approved by the Board of Directors on April 7, 2020, as well as its sales for the first quarter of 2020. 1- 2019 ANNUAL RESULTS • 11% sales increase on a comparable b...
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, communicates on the consequences on its activity of the COVID-19 pandemic and the measures it has taken to deal with it. MEDICREA® wishes to inform all of its shareholders as well as the financial markets, with the utmost t...
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matc...
LYON, France & NEW YORK--(BUSINESS WIRE)-- MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI (Adaptive Spine Intelligence) proprietary software platform, concierge expert services and technologies, announced today that it has received FDA-Clearance for UNiD® IB3D Patient-Matched interbody cages which completes its UNiD® ASI platform technology. UNiD® IB3D Patient-Matched interbody cages are 3D-printed...
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spi...
LYON, France & NEW YORK--(BUSINESS WIRE)-- MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI (Adaptive Spine Intelligence) proprietary software platform, concierge expert services and technologies, announced today that it has reached more than 5,000 cases with its proprietary UNiD® ASI technology platform and using patient-specific implants manufactured by MEDICREA®. MEDICREA® designed UNiD® ASI to as...
MEDICREA® Reports 2019 Annual Sales
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, today announced full year 2019 sales. (€ million) 2018 2019 Variation Variation at Constant Exchange Rate USA 15.6 17.9 +15% +9% Rest of the world 13.8 14.8 +7% +7% Tota...
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partner...
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announces that it is in active discussions with potential U.S. strategic partners in the spine industry with the intention to execute one or more strategic agreements that could materialize through a takeover of the Company,...
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Te...
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that the United States Patent Office has recently issued the Company 7 additional key patents related to the UNiD™ ASI proprietary technology platfor...
Medicrea Reports Third Quarter 2019 Financial Results
LYON, France & NEW YORK--(BUSINESS WIRE)-- The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the third quarter of 2019. €’million H1 2019 Q3 2019 YTD 09-2019 YTD 09-2018 (2) Restated Sales 16.1 8.2 24.3 24.3 Gross margin - % of sales 77...
Medicrea Reports Third Quarter 2019 Sales
LYON, France & NEW YORK--(BUSINESS WIRE)-- The Medicrea Group (Euronext Growth Paris - FR0004178572 - ALMED; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the third quarter of 2019. (€ millions) YTD September 2018 YTD September 2019 Variation Variation at Constant Exchange Rate USA Rest of the wo...
MEDICREA® Hosts Third Annual User Group Meeting (MAIA) in Lyon, Franc...
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that it hosted the third edition of its annual MEDICREA® Artificial Intelligence and Analytics (MAIA) meeting in Lyon, France from September 12-14, and continued their conversations at the 54th annual...
Medicrea Reports First Half 2019 Financial Results
LYON, France & NEW YORK--(BUSINESS WIRE)-- The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the first half of 2019, as approved by the Board of Directors on September 16, 2019. €’million H1 2019 H1 2018 (2) Restated Sales Gross margin - % of sales EBITDA ...
MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UN...
LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that it has received FDA-Clearance for TULIP GENESIS™ which completes its UNiD™ ASI platform technology. With the FDA clearance of the TULIP GENESIS™, MEDICREA® completes its UNiD™ ASI platform by p...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.